| Old Articles: <Older 9081-9090 Newer> |
|---|
 |
Chemistry World
May 11, 2015
Phillip Broadwith |
Zoetis to sell or close 10 plants in cost-cutting drive The plan is expected to cost the former Pfizer subsidiary $400 -- 500 million over the next two years, and bring savings of $300 million per year.   |
Chemistry World
May 11, 2015
Phillip Broadwith |
Takeda offers $2.4bn to settle diabetes litigation Japanese drug company Takeda has put aside $2.7 billion to cover settlements of US product liability court cases relating to its diabetes drug Actos (pioglitazone). |
Information Today
May 7, 2015 |
PCG Will Promote Japanese Medical Database PCG will help Japanese medical publisher Meteo to facilitate the expansion of Meteo's Medical*Online-E information service into North and South America. |
Chemistry World
May 5, 2015
Anthony King |
Merger creates biggest supplier of unlicensed drugs Specialty pharma company Clinigen is to buy its rival Idis, making it the market leader in ethical unlicensed drug supply. |
Chemistry World
May 1, 2015
Rebecca Trager |
Generics firms in three-way takeover battle US-based Mylan is gunning for Irish rival Perrigo, but the deal is overshadowed by a bid for Mylan itself from Israel's powerhouse Teva. |
Information Today
April 30, 2015 |
Nature Publishing Group Adds New Format to Its Journals Portfolio Nature Reviews Disease Primersonline will contain review articles called Primers that have overviews of diseases and disorders. |
AskMen.com
Benjamin Ryan |
Propecia Side Effects Even though the balding wonder drug Propecia was approved back in 1997 and has been prescribed to millions of follicle-challenged guys since then, scientists still don't have a firm handle on how safe it is. |
Chemistry World
April 22, 2015
Phillip Broadwith |
Daiichi Sankyo steps out after Sun-Ranbaxy merger Japanese firm Daiichi Sankyo has sold off its entire stake in India's Sun Pharmaceuticals, following Sun's takeover of Indian rival Ranbaxy, in which Daiichi was the controlling shareholder. |
Fast Company
John Paul Titlow |
Alternative Medicine Or Death Wish? The FDA Wants Its Say The U.S. Food and Drug Administration is looking to put a microscope to the homeopathic medicine industry and explore the possibility of regulating it. |
Chemistry World
April 13, 2015
Emma Stoye |
Generics giant Mylan offers $30 billion for Perrigo Generics manufacturer Mylan has made an unsolicited, public offer to buy Ireland-based rival Perrigo for $205 per share. |
| <Older 9081-9090 Newer> Return to current articles. |
